OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Cited by CrossRef (26)

  1. Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, Yoshie Itakura, Sakura Kirino, Kento Inada, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Rohit Loomba, Namiki Izumi. Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup. IJMS 2020;22:40
    https://doi.org/10.3390/ijms22010040
  2. Nobuharu Tamaki, Masayuki Kurosaki, Sakura Kirino, Namiki Izumi. Diagnostic accuracy of hepatocellular carcinoma risk prediction models during antiviral therapy in chronic hepatitis B patients. Hepatology Research 2021;51:1170
    https://doi.org/10.1111/hepr.13684
  3. Se Young Jang, Won Young Tak, Soo Young Park, Young-Oh Kweon, Yu Rim Lee, Gyeonghwa Kim, Keun Hur, Man-Hoon Han, Won Kee Lee. Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases. Ann Lab Med 2021;41:302
    https://doi.org/10.3343/alm.2021.41.3.302
  4. Sven M. Francque. Biomarkers for Liver Fibrosis Post–Liver Transplantation: Not As Easy As It Looks. Liver Transpl. 2021;27:327
    https://doi.org/10.1002/lt.25927
  5. Chien-Hung Chen, Tsung-Hui Hu, Jing-Houng Wang, Hsueh-Chou Lai, Chao-Hung Hung, Sheng-Nan Lu, Cheng-Yuan Peng. A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy. Cancers 2022;14:5063
    https://doi.org/10.3390/cancers14205063
  6. Yu‐Ming Cheng, Chia‐Chi Wang. Comparison of Mac‐2 binding protein glycosylation isomer (M2BPGi) with AST to platelet ratio index (APRI), fibrosis 4 Score (FIB‐4), and nonalcoholic fatty liver disease (NAFLD) fibrosis score (NFS) for NAFLD patients. Adv in Digestive Medicine 2023;10:87
    https://doi.org/10.1002/aid2.13315
  7. Sakura Kirino, Nobuharu Tamaki, Masayuki Kurosaki, Kento Inada, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Namiki Izumi. Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment. Journal of Viral Hepatitis 2021;28:787
    https://doi.org/10.1111/jvh.13473
  8. Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, Yoshie Itakura, Kento Inada, Sakura Kirino, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Namiki Izumi. Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease. J of Gastro and Hepatol 2021;36:2960
    https://doi.org/10.1111/jgh.15589
  9. Minjeong Nam, Mina Hur, Mikyoung Park, Hanah Kim. Novel Usefulness of Krebs von den Lungen 6 (KL-6) with Hemoglobin and Lactate Dehydrogenase for Assessing Bone Marrow Fibrosis. Diagnostics 2022;12:628
    https://doi.org/10.3390/diagnostics12030628
  10. Kwang Il Seo, Hyunyong Hwang, Byung Cheol Yun, Hyung Hwan Moon, Young Il Choi, Dong Hoon Shin, Myunghee Yoon. A prospective study of the correlation between hepatic fibrosis and noninvasively measured fibrosis markers including serum M2BPGi and acoustic radiation force impulse elastography. KMJ 2022;37:146
    https://doi.org/10.7180/kmj.22.110
  11. Yiyoung Kwon, Eun Sil Kim, Yon Ho Choe, Mi Jin Kim. Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children. Front. Pediatr. 2022;10
    https://doi.org/10.3389/fped.2022.846273
  12. Kento Inada, Nobuharu Tamaki, Masayuki Kurosaki, Sakura Kirino, Koji Yamashita, Yuka Hayakawa, Mayu Higuchi, Kenta Takaura, Shun Kaneko, Chiaki Maeyashiki, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Namiki Izumi. Validation of magnetic resonance elastography plus fibrosis‐4 for significant fibrosis in nonalcoholic fatty liver disease. J of Gastro and Hepatol 2022;37:1726
    https://doi.org/10.1111/jgh.15893
  13. Saut Horas H. Nababan, Kemal Fariz Kalista, Chyntia O.M. Jasirwan, Juferdy Kurniawan, Cosmas Rinaldi A. Lesmana, Andri S. Sulaiman, Irsan Hasan, Rino A. Gani. Mac-2 Binding Protein Glycosylation Isomer for Screening High-Risk Esophageal Varices in Liver Cirrhotic Patient. Livers 2021;1:60
    https://doi.org/10.3390/livers1020006
  14. Takako Inoue, Yasuhito Tanaka. Comprehensive Guide to Hepatitis Advances. 2021.
    https://doi.org/10.1016/B978-0-323-98368-6.00009-4
  15. Pei-Shan Wu, Yun-Cheng Hsieh, Kuei-Chuan Lee, Yi-Hsiang Huang, Ming-Chih Hou, Han-Chieh Lin, Chen-Hua Liu. Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients. PLoS ONE 2021;16:e0258589
    https://doi.org/10.1371/journal.pone.0258589
  16. Nobuharu Tamaki, Masayuki Kurosaki, Daniel Q. Huang, Rohit Loomba. Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease. Hepatology Research 2022;52:497
    https://doi.org/10.1111/hepr.13764
  17. Tyng‐Yuan Jang, Chung‐Feng Huang, Ming‐Lun Yeh, Ching‐I Huang, Chia‐Yen Dai, Pei‐Chien Tsai, Po‐Yau Hsu, Yi‐Ju Wei, Nai‐Jen Hou, Po‐Cheng Liang, Yi‐Hung Lin, Chih‐Wen Wang, Ming‐Yen Hsieh, Zu‐Yau Lin, Jee‐Fu Huang, Ming‐Lung Yu, Wan‐Long Chuang. Serum Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein expression predicts disease severity in nonalcoholic steatohepatitis patients. The Kaohsiung J of Med Scie 2022;38:261
    https://doi.org/10.1002/kjm2.12474
  18. Mayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, Kento Inada, Sakura Kirino, Koji Yamashita, Yuka Hayakawa, Leona Osawa, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Rohit Loomba, Nobuyuki Enomoto, Namiki Izumi. Longitudinal association of magnetic resonance elastography‐associated liver stiffness with complications and mortality. Aliment Pharmacol Ther 2022;55:292
    https://doi.org/10.1111/apt.16745
  19. Nobuharu Tamaki, Kento Imajo, Suzanne R. Sharpton, Jinho Jung, Nancy Sutter, Nobuyoshi Kawamura, Masato Yoneda, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Masayuki Kurosaki, Namiki Izumi, Atsushi Nakajima, Rohit Loomba. Two-Step Strategy, FIB-4 Followed by Magnetic Resonance Elastography, for Detecting Advanced Fibrosis in NAFLD. Clinical Gastroenterology and Hepatology 2023;21:380
    https://doi.org/10.1016/j.cgh.2022.01.023
  20. Ming Jian Lian, Zhi Qi Chen, Qian Ming Wang, Gang Sen Zheng, Guo Lin Hong. Diagnostic accuracy of mac‐2‐binding protein glycosylation isomer for diagnosing hepatitis B‐related fibrosis: A meta‐analysis. J of Digest Diseases 2022;23:550
    https://doi.org/10.1111/1751-2980.13140
  21. Hideyuki Tamai, Jumpei Okamura, Takashi Ohoshi, Hisao Wakasaki. Measurements of Serum Mac-2-Binding Protein Glycosylation Isomer and Shear Wave Velocity in Health Checkups Are Useful in Screening for Non-Alcoholic Steatohepatitis. Healthcare 2021;9:523
    https://doi.org/10.3390/healthcare9050523
  22. Jeanne Perpétue Vincent, Gibril Ndow, Shintaro Ogawa, Amie Ceesay, Ramou Njie, Bakary Sanneh, Ignatius Baldeh, Umberto D’Alessandro, Maimuna Mendy, Mark Thursz, Isabelle Chemin, Yasuhito Tanaka, Maud Lemoine, Yusuke Shimakawa. Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa. J Glob Health 2022;12
    https://doi.org/10.7189/jogh.12.04076
  23. Nobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, Nami Mori, Keiji Tsuji, Chitomi Hasebe, Kouji Joko, Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi, Hiroyuki Kimura, Hitoshi Yagisawa, Hiroyuki Marusawa, Masahiko Kondo, Yuji Kojima, Hideo Yoshida, Yasushi Uchida, Toshifumi Tada, Shinichiro Nakamura, Satoshi Yasuda, Hidenori Toyoda, Rohit Loomba, Namiki Izumi. Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus. Hepatol Commun 2022;6:461
    https://doi.org/10.1002/hep4.1833
  24. Sakura Kirino, Nobuharu Tamaki, Masayuki Kurosaki, Shun Kaneko, Kento Inada, Yuki Tanaka, Shun Ishido, Koji Yamashita, Tsubasa Nobusawa, Hiroaki Matsumoto, Yuka Hayakawa, Tatsuya Kakegawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Ryuichi Okamoto, Namiki Izumi. Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B. Hepatology Research 2023;53:35
    https://doi.org/10.1111/hepr.13839
  25. Mina Hur, Mikyoung Park, Hee-Won Moon, Won Hyeok Choe, Chae Hoon Lee. Comparison of Non-Invasive Clinical Algorithms for Liver Fibrosis in Patients With Chronic Hepatitis B to Reduce the Need for Liver Biopsy: Application of Enhanced Liver Fibrosis and Mac-2 Binding Protein Glycosylation Isomer. Ann Lab Med 2022;42:249
    https://doi.org/10.3343/alm.2022.42.2.249
  26. Yu-Ming Cheng, Chia-Chi Wang. Serum Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) Can Predict Mild or Significant Liver Fibrosis in Non-alcoholic Fatty Liver Disease. Hepat Mon 2021;21
    https://doi.org/10.5812/hepatmon.115400